viewPan African Resources plc

Pan African Resources Plc - Trading Statement & Notice of Results

Pan African Resources Plc - Trading Statement & Notice of Results

Pan African Resources Plc - Trading Statement & Notice of Results

PR Newswire

Pan African Resources PLC
(Incorporated and registered in England and Wales under Companies Act 1985
with registered number 3937466 on 25 February 2000)
Share code on AIM: PAF
Share code on JSE: PAN
ISIN: GB0004300496

(“Pan African” or “the Company”)


In terms of paragraph 3.4(b) of the Listings Requirements of the JSE Limited, a listed company is required to publish a trading statement as soon as it is satisfied that a reasonable degree of certainty exists that the financial results for the period to be reported upon next, will differ by at least 20% from those of the previous corresponding period.

The group’s presentation currency changed for the financial year ended 30 June 2019 (“current reporting period”) to United States dollars (“USD”) from pounds sterling (“GBP”). Reporting in USD provides a more comparable presentation currency for the group’s financial position, financial performance and cash flow. All group subsidiaries are incorporated in South Africa and their functional currency is South African rand (“ZAR”). The group’s business is conducted in ZAR and the accounting records are maintained in this same currency, except precious metal product sales, which are conducted in USD prior to conversion into ZAR.

The ZAR:USD exchange rate affects the reporting of results in USD. For the current reporting period, the average ZAR:USD exchange rate is used and, in the event of material transactions, the exchange rate on the date of the transaction is used to translate earnings from ZAR to USD.

During the current reporting period, the average ZAR:USD exchange rate was R14.19:1 (2018: R12.85:1) and the closing ZAR:USD exchange rate was R14.08:1 (2018: R13.72:1). The year-on-year change in the average and closing exchange rates of 10.4% and 2.6%, respectively, must be taken into account for the purposes of translating and comparing year-on-year results. Furthermore, the weighted average number of shares in issue increased by 6.6% to 1,928.3 million shares (2018: 1,809.7 million shares), following the disposal of 130 million Pan African shares held by PAR Gold (Pty) Ltd on 29 May 2018.

Pan African advises shareholders that its USD earnings per share (“EPS”) and headline earnings per share (“HEPS”) in respect of its total and continuing operations for the current reporting period are expected to be as follows:

Year ended
Year ended

30 June 2018
Year ended
30 June 2019 30 June 2019
Expected results Expected USD ranges
(USD cents) % change
Lower range Upper range GBP USD Lower range Upper range
(pence)(4) (cents)(3)
Total operations
EPS(1) 1.63 2.32 (5.15) (6.79) 124% 134%
HEPS (2) 1.14 1.24 0.73 0.99 15% 25%
Continuing operations
EPS(1) 1.93 2.02 0.63 0.86 124% 134%
HEPS (2) 1.12 1.27 1.08 1.46 (23%) (13%)


(1)  EPS in the current reporting period includes the financial impact of a reversal of an impairment charge of USD17.9 million which was recognised following commencement of development at Evander Mines’ 8 Shaft Pillar Project (“Pillar Project”). In the corresponding reporting period, following the cessation of large-scale underground mining operations at Evander Mines in May 2018, an impairment charge of USD140.3 million was recognised of which USD129.5 million related to discontinued operations and USD10.8 million, which related to the ETRP, was recognised as part of continuing operations. The reversal of the impairment charge relates specifically to the property, plant and equipment previously impaired at Evander Mines in the corresponding reporting period which will be utilised by the Pillar Project.

(2)  The movement in continuing operations HEPS is predominantly due to:

-     The weighted average number of shares in issue increasing by 6.6%; and

-     The ZAR:USD exchange rate depreciating by 10.4% to R14.19:1 (2018: R12.85:1), with the average USD gold price received decreasing by 2.7% to USD1,266/oz
(2018: USD1,301/oz).

(3)  EPS and HEPS in USD, using the average exchange rates for the corresponding reporting period.

(4)  As previously presented, given that the corresponding reporting period’s presentation currency was GBP.

The financial information contained in this announcement has neither been reviewed nor audited by the company’s auditors. The group’s provisional summarised audited year-end results for the year ended 30 June 2019 will be released on 18 September 2019.

For further information on Pan African, please visit the company’s website at www.panafricanresources.com

11 September 2019

Contact information
Corporate Office
The Firs Office Building
2nd Floor, Office 204
Cnr. Cradock and Biermann Avenues
Rosebank, Johannesburg
South Africa
Office:   + 27 (0)11 243 2900
[email protected]
Registered Office
Suite 31
Second Floor
107 Cheapside
United Kingdom
Office: + 44 (0)20 7796 8644
Cobus Loots     
Pan African Resources PLC   
Chief Executive Officer 
Office: + 27 (0)11 243 2900                                         
Deon Louw
Pan African Resources PLC
Financial Director
Office: + 27 (0)11 243 2900
Phil Dexter/Jane Kirton
St James's Corporate Services Limited
Company Secretary
Office: + 44 (0)20 7796 8644
John Prior
Numis Securities Limited
Nominated Adviser and Joint Broker
Office: +44 (0)20 7260 1000
Ciska Kloppers
Questco Corporate Advisory Proprietary Limited
JSE Sponsor
Office: + 27 (0)11 011 9200
Ross Allister/David McKeown
Peel Hunt LLP
Joint Broker
Office: +44 (0)20 7418 8900
Julian Gwillim
Aprio Strategic Communications
Public & Investor Relations SA
Office: +27 (0)11 880 0037         
Jeffrey Couch/Thomas Rider/Niel Elliot
BMO Capital Markets Limited
Joint Broker
Office: +44 (0)20 7236 1010
Bobby Morse/Chris Judd
Public and Investor Relations UK
Office: +44 (0)20 7466 5000
[email protected]
Website: www.panafricanresources.com

Quick facts: Pan African Resources plc

Price: 11.5

Market: AIM
Market Cap: £221.76 m

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Investor Update: Faron Pharma encouraged by Clevegen efficacy and tolerability

Top stories from the Proactive Investors UK newsroom. Faron Pharmaceuticals (LON:FARN) has reported increased immune cell activity in its ongoing phase I/II trial of solid tumour cancer treatment Clevegen. All nine patients treated also tolerated high dose levels. South African gold...

on 12/7/19